Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan G C van Hasselt

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
CPT: Pharmacometrics & Systems Pharmacology|February 20, 2024
Quantitative modeling of tumor dynamics and development of drug resistance in non-small cell lung cancer patients treated with erlotinibAnyue Yin, G D Marijn Veerman, Johan G C van Hasselt, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 15, 2017
Prediction of human CNS pharmacokinetics using a physiologically-based pharmacokinetic modeling approachYumi Yamamoto, Pyry A Välitalo, Yin Cheong Wong, et al.
The Journal of Antimicrobial Chemotherapy|December 22, 2016
Population pharmacokinetics of cefazolin before, during and after cardiopulmonary bypass to optimize dosing regimens for children undergoing cardiac surgeryPieter A J G De Cock, Hussain Mulla, Sarah Desmet, et al.
British Journal of Clinical Pharmacology|July 28, 2020
Why we should sample sparsely and aim for a higher target: Lessons from model-based therapeutic drug monitoring of vancomycin in intensive care patientsTingjie Guo, Reinier M van Hest, Lucas M Fleuren, et al.
Pharmaceutical Research|August 25, 2020
Optimizing Predictive Performance of Bayesian Forecasting for Vancomycin Concentration in Intensive Care PatientsTingjie Guo, Reinier M van Hest, Laura B Zwep, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 10, 2026
Pharmacokinetic and Pharmacodynamic Evaluations of Oral Moxifloxacin for Enterococcus faecalis EndocarditisMagnus Bock, Johan G C Van Hasselt, Kurt Fuursted, et al.
Scientific Reports|November 9, 2017
A Comparison of mRNA Sequencing with Random Primed and 3'-Directed LibrariesYuguang Xiong, Magali Soumillon, Jie Wu, et al.
Pharmaceutical Research|November 20, 2016
A Generic Multi-Compartmental CNS Distribution Model Structure for 9 Drugs Allows Prediction of Human Brain Target Site ConcentrationsYumi Yamamoto, Pyry A Välitalo, Dirk-Jan van den Berg, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 30, 2025
Target attainment of benzylpenicillin in patients with infective endocarditisMagnus Bock, Johan G C Van Hasselt, Kurt Fuursted, et al.
The Journal of Antimicrobial Chemotherapy|October 12, 2023
Rifampicin reduces plasma concentration of linezolid in patients with infective endocarditisMagnus Bock, Johan G C Van Hasselt, Franziska Schwartz, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
CPT: Pharmacometrics & Systems Pharmacology|February 20, 2024
Quantitative modeling of tumor dynamics and development of drug resistance in non-small cell lung cancer patients treated with erlotinibAnyue Yin, G D Marijn Veerman, Johan G C van Hasselt, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 15, 2017
Prediction of human CNS pharmacokinetics using a physiologically-based pharmacokinetic modeling approachYumi Yamamoto, Pyry A Välitalo, Yin Cheong Wong, et al.
The Journal of Antimicrobial Chemotherapy|December 22, 2016
Population pharmacokinetics of cefazolin before, during and after cardiopulmonary bypass to optimize dosing regimens for children undergoing cardiac surgeryPieter A J G De Cock, Hussain Mulla, Sarah Desmet, et al.
British Journal of Clinical Pharmacology|July 28, 2020
Why we should sample sparsely and aim for a higher target: Lessons from model-based therapeutic drug monitoring of vancomycin in intensive care patientsTingjie Guo, Reinier M van Hest, Lucas M Fleuren, et al.
Pharmaceutical Research|August 25, 2020
Optimizing Predictive Performance of Bayesian Forecasting for Vancomycin Concentration in Intensive Care PatientsTingjie Guo, Reinier M van Hest, Laura B Zwep, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 10, 2026
Pharmacokinetic and Pharmacodynamic Evaluations of Oral Moxifloxacin for Enterococcus faecalis EndocarditisMagnus Bock, Johan G C Van Hasselt, Kurt Fuursted, et al.
Scientific Reports|November 9, 2017
A Comparison of mRNA Sequencing with Random Primed and 3'-Directed LibrariesYuguang Xiong, Magali Soumillon, Jie Wu, et al.
Pharmaceutical Research|November 20, 2016
A Generic Multi-Compartmental CNS Distribution Model Structure for 9 Drugs Allows Prediction of Human Brain Target Site ConcentrationsYumi Yamamoto, Pyry A Välitalo, Dirk-Jan van den Berg, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 30, 2025
Target attainment of benzylpenicillin in patients with infective endocarditisMagnus Bock, Johan G C Van Hasselt, Kurt Fuursted, et al.
The Journal of Antimicrobial Chemotherapy|October 12, 2023
Rifampicin reduces plasma concentration of linezolid in patients with infective endocarditisMagnus Bock, Johan G C Van Hasselt, Franziska Schwartz, et al.
Pageof 4